Clinical Trials Directory

Trials / Unknown

UnknownNCT05036941

A Trial of Two Mask Systems in Preventing SARS CoV-2 in Healthcare Workers (HCW)

A Cluster Randomized Trial of Two Mask Systems (Acteev™ N95 + Acteev™ Fabric Masks vs. Standard N95 + Fabric Masks During Shifts & in Community) in Preventing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) in HCWs

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
1,600 (estimated)
Sponsor
Ascend Performance Materials · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

A cluster randomized trial will be conducted to evaluate the difference between an Acteev™ system (Acteev™ N95 masks YQD8008 during shifts+ Acteev™ fabric masks in community) and a standard system (standard N95 masks during shifts+ fabric masks in community) in preventing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2)in healthcare workers(HCWs).

Detailed description

This is a maximum 10-week (8-week intervention+2-week follow up) two-armed controlled study to investigate efficacy of Acteev™ system (Acteev™ N95 masks YQD8008 during shifts+ Acteev™ fabric masks in community) compared with standard system (standard N95 masks during shifts+ fabric masks in community) in HCWs working in high-risk hospital wards (ICU, emergency), against the prevention of SARS CoV-2 infection. Prospective HCWs will be identified for the study by the study investigator/study team and be invited for participation in the study. All study procedures will begin only after obtaining written informed consent from the subjects. Subjects will be randomized in one of the two arms mentioned below after meeting all the study eligibility criteria: Arm 1:Acteev™ system (Acteev™ N95 masks YQD8008 during shifts+ Acteev™ fabric masks in community) Arm 2: Standard system (standard N95 masks during shifts+ fabric masks in community).

Conditions

Interventions

TypeNameDescription
DEVICEActeev™ MasksParticipants will wear the mask on every shift for 8 consecutive weeks. Participants in Arm 1 will be supplied adequate number of Acteev™ N95 masks YQD8008 during 8-hour shift and Acteev™ fabric masks for community use.
DEVICEComparison MasksParticipants will wear the mask on every shift for 8 consecutive weeks. Participants in Arm 2 will be supplied with adequate number of standard N95 masks during 8-hour shift and fabric mask for community use.

Timeline

Start date
2021-11-13
Primary completion
2022-02-01
Completion
2022-02-01
First posted
2021-09-08
Last updated
2021-12-22

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT05036941. Inclusion in this directory is not an endorsement.